Catalyzing Neurological Innovation: Pharnext SCA’s Symphony of PleotherapyTM and AI-Driven Solutions in Advancing Patient-Centric Therapeutics
In the realm of pharmaceutical innovation, Pharnext SCA stands as a pioneering force, leveraging cutting-edge artificial intelligence (AI) methodologies to develop novel drugs for a spectrum of neurological diseases. This article delves into the technical intricacies of Pharnext’s groundbreaking PleotherapyTM approach, with a particular focus on its portfolio’s flagship products, PXT3003 and PXT864, designed to…